May 15, 2020
The Japanese Association for Infectious Diseases (JAID) has updated its pharmacotherapeutic approach guide to COVID-19 by adding information on Gilead Sciences’ Veklury (remdesivir) following its approval on May 7. The latest guide, which was published on May 14, cites information...read more